Human LAG3 (Lymphocyte Activation Gene 3 Protein) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-03725P

SDS-PAGE analysis of Human LAG3 (Lymphocyte Activation Gene 3 Protein) - Recombinant Protein, CAT# BLT-03725P, showing >85% purity under 15% SDS-PAGE (Reduced)
Human LAG3 (Lymphocyte Activation Gene 3 Protein) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-03725P
Regular price
$59500
$595.00
Sale price$44500
$445.00Save $150
/
Quantity Pricing
Pack Size | Price (USD) |
---|---|
500 µg | $1,030 (Fall Promotion) |
1 mg | $1,870 (Fall Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
Product Name | Recombinant Human Lymphocyte Activation Gene 3 (LAG3) Protein |
Product Overview | This recombinant human Lymphocyte Activation Gene 3 (LAG3) protein includes amino acids 23-434aa of the target gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id | P18627 |
Recommended Name | Lymphocyte activation gene 3 protein |
Gene Name | LAG3 |
Synonyms | Lymphocyte activation gene 3 protein;LAG3;LAG-3;Protein FDC;CD223 |
Species | Human |
Predicted Molecular Mass | 45.5 kDa |
Expression System | Mammalian Cell |
Expression Range | 23-434aa |
Tag | C-6His |
Purity | >85% |
Formulation | Lyophilized |
Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications | Positive Control; Immunogen; SDS-PAGE; WB |
Research Area | Immunology |
Target Function | Lymphocyte activation gene 3 protein: Inhibitory receptor on antigen activated T-cells. Delivers inhibitory signals upon binding to ligands, such as FGL1. FGL1 constitutes a major ligand of LAG3 and is responsible for LAG3 T-cell inhibitory function. Following TCR engagement, LAG3 associates with CD3-TCR in the immunological synapse and directly inhibits T-cell activation. May inhibit antigen-specific T-cell activation in synergy with PDCD1/PD-1, possibly by acting as a coreceptor for PDCD1/PD-1. Negatively regulates the proliferation, activation, effector function and homeostasis of both CD8(+) and CD4(+) T-cells. Also mediates immune tolerance: constitutively expressed on a subset of regulatory T-cells (Tregs) and contributes to their suppressive function. Also acts as a negative regulator of plasmacytoid dendritic cell (pDCs) activation. Binds MHC class II (MHC-II); the precise role of MHC-II-binding is however unclear.; May function as a ligand for MHC class II (MHC-II) on antigen-presenting cells (APC), promoting APC activation/maturation and driving Th1 immune response. |
Subcellular Location | [Lymphocyte activation gene 3 protein]: Cell membrane; Single-pass type I membrane protein.; [Secreted lymphocyte activation gene 3 protein]: Secreted. |
Tissue Specificity | Primarily expressed in activated T-cells and a subset of natural killer (NK) cells. |